| Stage | ULS | % of rev | SPXC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $816M | 100.00% | $715M | 100.00% | ULS ×1.14 |
| Gross profit | $417M | 51.10% | $280M | 39.12% | ULS +12.0pp |
| Operating income | $150M | 18.38% | $115M | 16.14% | ULS +2.2pp |
| Pre-tax income | $338M | 41.42% | $106M | 14.88% | ULS +26.5pp |
| Net income | $254M | 31.13% | $82M | 11.46% | ULS +19.7pp |
| Stage | ULS | SPXC | Gap · A − B |
|---|---|---|---|
| Revenue | $816M100.00% | $715M100.00% | ULS ×1.14 |
| Gross profit | 51.10%$417M | 39.12%$280M | ULS +12.0pp |
| Operating income | 18.38%$150M | 16.14%$115M | ULS +2.2pp |
| Pre-tax income | 41.42%$338M | 14.88%$106M | ULS +26.5pp |
| Net income |
| 31.13%$254M |
| 11.46%$82M |
| ULS +19.7pp |
No shared counterparties.